{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T07:41:33Z","timestamp":1794555693928,"version":"4.9.1"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Genetics"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.cancergen.2018.08.002","type":"journal-article","created":{"date-parts":[[2018,8,27]],"date-time":"2018-08-27T02:12:00Z","timestamp":1535335920000},"page":"41-46","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Myeloproliferative neoplasm with ABL1\/ETV6 rearrangement mimics chronic myeloid leukemia and responds to tyrosine kinase inhibitors"],"prefix":"10.1016","volume":"228-229","author":[{"given":"Wei","family":"Xie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sa A.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shimin","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. Jeffrey","family":"Medeiros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guilin","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cancergen.2018.08.002_bib0001","first-page":"1013","article-title":"Chromosome studies in human leukemia. II. chronic granulocytic leukemia","volume":"27","author":"Nowell","year":"1961","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.cancergen.2018.08.002_bib0002","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1177\/1947601912458584","article-title":"Structure, regulation, signaling, and targeting of abl kinases in cancer","volume":"3","author":"Hantschel","year":"2012","journal-title":"Genes Cancer"},{"key":"10.1016\/j.cancergen.2018.08.002_bib0003","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.leukres.2012.04.010","article-title":"ETV6 fusion genes in hematological malignancies: a review","volume":"36","author":"De Braekeleer","year":"2012","journal-title":"Leuk Res"},{"key":"10.1016\/j.cancergen.2018.08.002_bib0004","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0959-437X(05)80338-7","article-title":"Abl tyrosine kinase in signal transduction and cell-cycle regulation","volume":"3","author":"Wang","year":"1993","journal-title":"Curr Opin Genet Dev"},{"key":"10.1016\/j.cancergen.2018.08.002_bib0005","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.1101\/gad.12.15.2392","article-title":"The TEL\/ETV6 gene is required specifically for hematopoiesis in the bone marrow","volume":"12","author":"Wang","year":"1998","journal-title":"Genes Dev"},{"key":"10.1016\/j.cancergen.2018.08.002_bib0006","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1755-8166-6-39","article-title":"Myeloproliferative neoplasm with ETV6-ABL1 fusion: a case report and literature review","volume":"6","author":"Gancheva","year":"2013","journal-title":"Mol Cytogenet"},{"key":"10.1016\/j.cancergen.2018.08.002_bib0007","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3343\/alm.2017.37.1.77","article-title":"A case of chronic myeloid leukemia with rare variant ETV6\/ABL1 rearrangement","volume":"37","author":"Choi","year":"2017","journal-title":"Ann Lab Med"},{"key":"10.1016\/j.cancergen.2018.08.002_bib0008","doi-asserted-by":"crossref","first-page":"342","DOI":"10.3324\/haematol.2010.036673","article-title":"ETV6-ABL1-positive \"chronic myeloid leukemia\": clinical and molecular response to tyrosine kinase inhibition","volume":"96","author":"Perna","year":"2011","journal-title":"Haematologica"},{"key":"10.1016\/j.cancergen.2018.08.002_bib0009","first-page":"50","article-title":"An ETV6-ABL1 fusion in a patient with chronic myeloproliferative neoplasm: Initial response to Imatinib followed by rapid transformation into ALL","volume":"6","author":"Kakadia","year":"2016","journal-title":"Leuk Res Rep"},{"key":"10.1016\/j.cancergen.2018.08.002_bib0010","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1002\/gcc.20593","article-title":"Chronic phase of ETV6-ABL1 positive CML responds to imatinib","volume":"47","author":"Kawamata","year":"2008","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.cancergen.2018.08.002_bib0011","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1038\/sj.leu.2403697","article-title":"Broad molecular screening of an unclassifiable myeloproliferative disorder reveals an unexpected ETV6\/ABL1 fusion transcript","volume":"19","author":"Meyer-Monard","year":"2005","journal-title":"Leukemia"},{"key":"10.1016\/j.cancergen.2018.08.002_bib0012","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0165-4608(02)00609-X","article-title":"Chronic myelocytic leukemia with eosinophilia, t(9;12)(q34;p13), and ETV6-ABL gene rearrangement: case report and review of the literature","volume":"138","author":"Keung","year":"2002","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.cancergen.2018.08.002_bib0013","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1016\/j.leukres.2009.03.011","article-title":"Myeloproliferative disorder with eosinophilia and ETV6-ABL gene rearrangement: efficacy of second-generation tyrosine kinase inhibitors","volume":"33","author":"Nand","year":"2009","journal-title":"Leuk Res"},{"key":"10.1016\/j.cancergen.2018.08.002_bib0014","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.cancergencyto.2009.02.012","article-title":"Insertion (12;9)(p13;q34q34): a cryptic rearrangement involving ABL1\/ETV6 fusion in a patient with Philadelphia-negative chronic myeloid leukemia","volume":"192","author":"Kelly","year":"2009","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.cancergen.2018.08.002_bib0015","doi-asserted-by":"crossref","first-page":"3465","DOI":"10.1182\/blood.V99.9.3465","article-title":"Transient response to imatinib mesylate (STI571) in a patient with the ETV6-ABL t(9;12) translocation","volume":"99","author":"O'Brien","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.cancergen.2018.08.002_bib0016","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1046\/j.1365-2141.2003.04391.x","article-title":"Clinical and genetic studies of ETV6\/ABL1-positive chronic myeloid leukaemia in blast crisis treated with imatinib mesylate","volume":"122","author":"Barbouti","year":"2003","journal-title":"Br J Haematol"},{"key":"10.1016\/j.cancergen.2018.08.002_bib0017","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1159\/000448984","article-title":"Translocation (9;12)(q34.1;p13.?3) resulted in ETV6-ABL1 fusion in a patient with Philadelphia chromosome-negative chronic myelogenous leukemia","volume":"136","author":"Mori","year":"2016","journal-title":"Acta Haematol"},{"key":"10.1016\/j.cancergen.2018.08.002_bib0018","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1002\/(SICI)1098-2264(199711)20:3<299::AID-GCC11>3.0.CO;2-K","article-title":"BCR\/ABL-negative chronic myeloid leukemia with ETV6\/ABL fusion","volume":"20","author":"Andreasson","year":"1997","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.cancergen.2018.08.002_bib0019","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1002\/1098-2264(2000)9999:9999<1::AID-GCC1089>3.0.CO;2-1","article-title":"Molecular cytogenetic and clinical findings in ETV6\/ABL1-positive leukemia","volume":"30","author":"Van Limbergen","year":"2001","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.cancergen.2018.08.002_bib0020","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1002\/ajh.20873","article-title":"A fifteen-year cytogenetic remission following interferon treatment in a patient with an indolent ETV6-ABL positive myeloproliferative syndrome","volume":"82","author":"Mozziconacci","year":"2007","journal-title":"Am J Hematol"},{"key":"10.1016\/j.cancergen.2018.08.002_bib0021","doi-asserted-by":"crossref","first-page":"475","DOI":"10.3343\/alm.2014.34.6.475","article-title":"A cryptic ETV6\/ABL1 rearrangement represents a unique fluorescence in situ hybridization signal pattern in a patient with B acute lymphoblastic leukemia","volume":"34","author":"Song","year":"2014","journal-title":"Ann Lab Med"}],"container-title":["Cancer Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210776218302837?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210776218302837?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:43:15Z","timestamp":1761896595000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2210776218302837"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":21,"alternative-id":["S2210776218302837"],"URL":"https:\/\/doi.org\/10.1016\/j.cancergen.2018.08.002","relation":{},"ISSN":["2210-7762"],"issn-type":[{"value":"2210-7762","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Myeloproliferative neoplasm with ABL1\/ETV6 rearrangement mimics chronic myeloid leukemia and responds to tyrosine kinase inhibitors","name":"articletitle","label":"Article Title"},{"value":"Cancer Genetics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cancergen.2018.08.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}